Naohiko Akimoto
- Oncology top 10%
- Colorectal Cancer Screening and Detection 8
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment 12
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 6
-
- Gastric Cancer Management and Outcomes 17
- Metastasis and carcinoma case studies 5
-
- Gastrointestinal disorders and treatments 7
- Esophageal and GI Pathology 6
- Esophageal Cancer Research and Treatment 5
- Co-authors
- Shuji OginoTomotaka UgaiKana WuKenji FujiyoshiMarios GiannakisKimmie NgTsuyoshi HamadaRong Zhong
- Journals
- SHILAP Revista de lepidopterología (3 papers)The American Journal of Surgical Pathology (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Naohiko Akimoto
29 papers receiving 590 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 337
- Gastroenterology 56
- Pathology and Forensic Medicine 152
- Cancer Research 87
- Pulmonary and Respiratory Medicine 139
Countries citing papers authored by Naohiko Akimoto
This map shows the geographic impact of Naohiko Akimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiko Akimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiko Akimoto more than expected).
Fields of papers citing papers by Naohiko Akimoto
This network shows the impact of papers produced by Naohiko Akimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiko Akimoto. The network helps show where Naohiko Akimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naohiko Akimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 6 | |
| 17 | Rising incidence of early-onset colorectal cancer — a call to actionbreakdown → | 2020 | 419 |
| 18 | 2020 | 2 | |
| 19 | 2015 | 21 | |
| 20 | Validation of Pyrosequencing for the Analysis of KRAS Mutations in Colorectal Cancer | 2013 | 1 |
About Naohiko Akimoto
Naohiko Akimoto is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 35 papers that have together received 595 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (17 papers), Gastrointestinal Tumor Research and Treatment (12 papers), Colorectal Cancer Screening and Detection (8 papers), Gastrointestinal disorders and treatments (7 papers), Genetic factors in colorectal cancer (6 papers), Esophageal and GI Pathology (6 papers), Metastasis and carcinoma case studies (5 papers) and Esophageal Cancer Research and Treatment (5 papers). The work is most often cited by research in Oncology (337 citations), Gastroenterology (56 citations) and Pathology and Forensic Medicine (152 citations). Naohiko Akimoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Shuji Ogino, Tomotaka Ugai, Kana Wu, Kenji Fujiyoshi, Marios Giannakis, Kimmie Ng, Tsuyoshi Hamada, Rong Zhong, Yin Cao and Jun Omori. Their work appears in journals such as SHILAP Revista de lepidopterología, The American Journal of Surgical Pathology and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.